Viridian Therapeutics, Inc.

VRDN ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
S-8 Feb 28, 2024 S-8
10-K Feb 27, 2024 10-K
8-K Feb 27, 2024 8-K
SC 13G/A Feb 14, 2024 SC 13G/A
SC 13G/A Feb 14, 2024 SC 13G/A
SC 13G/A Feb 14, 2024
3 Feb 14, 2024 3
4 Feb 14, 2024 4
SC 13G/A Feb 14, 2024 AMENDMENT NO. 3 TO SCHEDULE 13G
SC 13G/A Feb 14, 2024
SC 13G/A Feb 13, 2024 SCHEDULE 13G/A
4 Feb 7, 2024 4
SC 13G Jan 29, 2024 SC 13G
SC 13G/A Jan 29, 2024
4 Jan 24, 2024 4
SC 13D/A Jan 24, 2024 SC 13D/A
SC 13G Jan 24, 2024
8-K Jan 19, 2024 8-K
424B5 Jan 19, 2024 424B5
424B5 Jan 17, 2024 424B5
3 Jan 12, 2024 3
SC 13G Jan 10, 2024
8-K Jan 8, 2024 8-K
144 Dec 18, 2023
8-K Dec 18, 2023 8-K
← Newer Page 7 of 33 · 815 filings Older →